BuCE Versus BuME as Conditioning Therapy in Non-Hodgkin's Lymphoma

NCT03794167 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Non-hodgkin Lymphoma

Interventions

DRUG: Busulfan
DRUG: Cyclophosphamide
DRUG: Etoposide
DRUG: Melphalan

Sponsor

Soonchunhyang University Hospital